MedPath

The effect of labetolol on reducing bleeding during and after functional endoscopic sinus surgery(FESS)

Not Applicable
Conditions
Chronic sinusitis.
Abscess empyema infection suppuration (chronic) of sinus (accessory)(nasal)
Registration Number
IRCT201511295225N6
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
32
Inclusion Criteria

informed consent of patients,age between 20 and 60 years old,ASA class I & II, no contraindication for using study drugs,scheduled for functional endoscopic sinus surgery (FESS) Exclusion criteria: need for a different anesthetic regimen, any positive history for coagulation disorders, cerebral/cardiac ischemia, liver,kidney,lung,heart disease or endocrinopathies

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding. Timepoint: Amount of bleeding during surgery. Method of measurement: Checking the amount of blood in suction container at the end of surgery.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath